NLTX logo

Neoleukin Therapeutics (NLTX) Book Value

NLTX Annual Book Value

$94.33 M
-$48.53 M-33.97%

31 December 2022

NLTX Book Value Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NLTX Quarterly Book Value

$75.23 M
-$4.34 M-5.46%

30 September 2023

NLTX Quarterly Book Value Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NLTX Book Value Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-34.0%-28.8%
3 y3 years-33.4%-62.5%
5 y5 years-4.6%-1.9%

NLTX Book Value High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-50.7%-62.4%

Neoleukin Therapeutics Book Value History

DateAnnualQuarterly
Sept 2023
-
$75.23 M(-5.5%)
June 2023
-
$79.58 M(-2.2%)
Mar 2023
-
$81.36 M(-13.8%)
Dec 2022
$94.33 M(-34.0%)
$94.33 M(-10.7%)
Sept 2022
-
$105.65 M(-9.5%)
June 2022
-
$116.71 M(-10.3%)
Mar 2022
-
$130.09 M(-8.9%)
Dec 2021
$142.86 M(-25.3%)
$142.86 M(-7.7%)
Sept 2021
-
$154.87 M(-7.3%)
June 2021
-
$167.07 M(-6.6%)
Mar 2021
-
$178.97 M(-6.4%)
Dec 2020
$191.22 M(+35.0%)
$191.22 M(-4.6%)
Sept 2020
-
$200.34 M(+55.7%)
June 2020
-
$128.70 M(-6.1%)
Mar 2020
-
$137.12 M(-3.2%)
Dec 2019
$141.69 M(+95.0%)
$141.69 M(+111.9%)
Sept 2019
-
$66.88 M(-7.5%)
June 2019
-
$72.33 M(+1.1%)
Mar 2019
-
$71.54 M(-1.6%)
Dec 2018
$72.67 M
$72.67 M(-5.3%)
DateAnnualQuarterly
Sept 2018
-
$76.72 M(-15.4%)
June 2018
-
$90.68 M(+5.7%)
Mar 2018
-
$85.83 M(-13.2%)
Dec 2017
$98.89 M(-31.6%)
$98.89 M(-13.3%)
Sept 2017
-
$114.09 M(-8.4%)
June 2017
-
$124.61 M(-9.0%)
Mar 2017
-
$136.94 M(-5.3%)
Dec 2016
$144.66 M(+33.4%)
$144.66 M(-6.9%)
Sept 2016
-
$155.36 M(+68.7%)
June 2016
-
$92.09 M(-10.1%)
Mar 2016
-
$102.39 M(-5.6%)
Dec 2015
$108.42 M(+199.9%)
$108.42 M(-4.9%)
Sept 2015
-
$114.03 M(+341.8%)
June 2015
-
$25.81 M(-14.2%)
Mar 2015
-
$30.08 M(-16.8%)
Dec 2014
$36.15 M(-155.0%)
$36.15 M(-17.8%)
Sept 2014
-
$43.98 M(-12.1%)
June 2014
-
$50.02 M(-9.2%)
Mar 2014
-
$55.10 M(-183.9%)
Dec 2013
-$65.69 M(+28.6%)
-$65.69 M
Dec 2012
-$51.10 M
-

FAQ

  • What is Neoleukin Therapeutics annual book value?
  • What is the all time high annual book value for Neoleukin Therapeutics?
  • What is Neoleukin Therapeutics annual book value year-on-year change?
  • What is Neoleukin Therapeutics quarterly book value?
  • What is the all time high quarterly book value for Neoleukin Therapeutics?
  • What is Neoleukin Therapeutics quarterly book value year-on-year change?

What is Neoleukin Therapeutics annual book value?

The current annual book value of NLTX is $94.33 M

What is the all time high annual book value for Neoleukin Therapeutics?

Neoleukin Therapeutics all-time high annual book value is $191.22 M

What is Neoleukin Therapeutics annual book value year-on-year change?

Over the past year, NLTX annual book value has changed by -$48.53 M (-33.97%)

What is Neoleukin Therapeutics quarterly book value?

The current quarterly book value of NLTX is $75.23 M

What is the all time high quarterly book value for Neoleukin Therapeutics?

Neoleukin Therapeutics all-time high quarterly book value is $200.34 M

What is Neoleukin Therapeutics quarterly book value year-on-year change?

Over the past year, NLTX quarterly book value has changed by -$30.41 M (-28.79%)